ImmunoGen (IMGN) Q1 2022 Earnings Call Transcript : vimarsan

IMGN earnings call for the period ending March 31, 2022.

Related Keywords

China , Beijing , Shanghai , Russia , Huadong , Guangdong , Ukraine , Mark Enyedy , Andy Hsieh , Joe Catanzaro , John Newman , Jessica Fye , Etzer Darout , Andy Hsieh William Blair , Joe Catanzaro Piper Sandler , Kristen Harrington Smith , Piper Sandler , Anna Berkenblit , Michael Schmidt Guggenheim , Kelly Shi Jefferies , Jonathan Chang , John Newman Canaccord Genuity , Dsusan Altschuller , Courtney Okonek , Michael Schmidt , Kelly Shi , William Blair , Company Analyst , Courtneyo Konek , Risk Factors , Chief Executive , Molecular Cancer Therapeutics , Market Access Strategy , Huadong Medicine , Boris Peaker , Guggenheim Securities ,